Dishman Carbogen Amcis Ltd.
| BSE: 540701 | Sector: Health care |
| NSE: DCAL | ISIN Code: INE385W01011 |
| BSE 16:00 | 12 May | 164.35 |
-25.75 (-13.55%) |
OPEN
176.80 |
HIGH
177.60 |
LOW
160.30 |
| NSE 16:00 | 12 May | 164.25 |
-26.15 (-13.73%) |
OPEN
175.00 |
HIGH
177.50 |
LOW
160.00 |
| OPEN | 176.80 |
| PREVIOUS CLOSE | 190.10 |
| VOLUME | 453986 |
| 52-Week high | 216.65 |
| 52-Week low | 63.45 |
| P/E | |
| Mkt Cap.(Rs cr) | 2,577 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Dishman Carbogen Amcis Ltd. (DCAL) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 702.65 | -5.20 | -0.73 | 3211.14 |
| Dr Reddy's Labs | 5302.00 | 8.40 | 0.16 | 2937.70 |
| Cipla | 899.10 | 8.35 | 0.94 | 2318.17 |
| Aurobindo Pharma | 1016.25 | -14.55 | -1.41 | 1872.74 |
| Cadila Health. | 646.95 | 17.25 | 2.74 | 1412.90 |
| Divi's Lab. | 4077.00 | 2.35 | 0.06 | 1372.71 |
| Glenmark Pharma. | 623.85 | -0.70 | -0.11 | 1354.55 |
| Alkem Lab | 3003.00 | -29.35 | -0.97 | 1264.42 |
| Alembic Pharma | 950.90 | -1.85 | -0.19 | 969.40 |
| Torrent Pharma. | 2724.00 | 9.10 | 0.34 | 938.51 |
| Gland Pharma | 2858.60 | -7.55 | -0.26 | 772.86 |
| Lupin | 1210.75 | 13.15 | 1.10 | 727.55 |
| Ipca Labs. | 2140.35 | -19.85 | -0.92 | 652.46 |
| Abbott India | 16220.00 | 26.45 | 0.16 | 592.93 |
| Fortis Health. | 230.70 | -5.45 | -2.31 | 513.33 |
| Pfizer | 5347.80 | -53.90 | -1.00 | 509.13 |
| Sanofi India | 7751.10 | -102.25 | -1.30 | 477.60 |
| Natco Pharma | 925.00 | -2.15 | -0.23 | 474.50 |
| Apollo Hospitals | 3197.45 | -61.85 | -1.90 | 470.30 |
| Granules India | 336.50 | -23.40 | -6.50 | 444.07 |
Quick Links for Dishman Carbogen Amcis:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
